ICP
EW icon

Interchange Capital Partners’s Edwards Lifesciences EW Stock Holding History

Interchange Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
+3,948
New +$331K 0.07% 258
2024
Q3 		– Sell
-2,607
Closed -$241K – 292
2024
Q2 		$241K Buy
+2,607
New +$231K 0.09% 228
2021
Q2 		– Sell
-2,357
Closed -$211K – 134
2021
Q1 		$211K Sell
2,357
-618
-21% -$52.2K 0.11% 218
2020
Q4 		$271K Buy
+2,975
New +$247K 0.15% 160

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Interchange Capital Partners's EW Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,948 shares worth $357K. The stake represents 0.07% of the portfolio and ranks #258 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in EW as recently as Q2 2024.

Interchange Capital Partners first reported a position in EW in Q4 2020 and has held it in 4 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Interchange Capital Partners held 3,948 shares of Edwards Lifesciences worth $357K as of Q2 2026.
  • Edwards Lifesciences was a new Interchange Capital Partners position in Q2 2026.
  • Edwards Lifesciences made up 0.07% of Interchange Capital Partners's portfolio in Q2 2026, its #258 holding.
  • Interchange Capital Partners first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 4 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.